Bucillamine use for rheumatoid arthritis and type 2 diabetes mellitus are associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy
View ORCID ProfileTakahiro Tsuji, Sari Iwasaki, View ORCID ProfileKeishi Makita, Shota Furukawa, Kanako Watanabe-Kusunoki, Sayo Takeda-Otera, Takahito Itoh, Mamiko Shimamoto, Hiroaki Yamaji, Tomomasa Yoshimura, View ORCID ProfileJunya Yamamoto, Takashi Kudo, View ORCID ProfileMakoto Kondo, View ORCID ProfileHiroshi Kataoka, View ORCID ProfileMasaya Mukai, Yukito Kaga, Miku Yoshinari, Yuka Nishibata, Sakiko Masuda, Utano Tomaru, Akihiro Ishizu, Yuichiro Fukasawa, View ORCID ProfileSeiji Hashimoto, Saori Nishio
doi: https://doi.org/10.1101/2022.12.02.22282616
Takahiro Tsuji
1Department of Pathology, Sapporo City General Hospital, Hokkaido, Japan
MDSari Iwasaki
1Department of Pathology, Sapporo City General Hospital, Hokkaido, Japan
5Department of Pathology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan
MDKeishi Makita
1Department of Pathology, Sapporo City General Hospital, Hokkaido, Japan
11Department of Pathology, Oji General Hospital, Tomakomai, Hokkaido, Japan
MDShota Furukawa
2Department of Nephrology, Sapporo City General Hospital, Hokkaido, Japan
9Department of Internal Medicine, Kushiro Red Cross Hospital, Hokkaido, Japan
MDKanako Watanabe-Kusunoki
9Department of Internal Medicine, Kushiro Red Cross Hospital, Hokkaido, Japan
MDSayo Takeda-Otera
2Department of Nephrology, Sapporo City General Hospital, Hokkaido, Japan
MDTakahito Itoh
10Department of Cardiology, Oji General Hospital, Tomakomai, Hokkaido, Japan
MDMamiko Shimamoto
2Department of Nephrology, Sapporo City General Hospital, Hokkaido, Japan
MDHiroaki Yamaji
12Department of Nephrology, Otaru General Hospital, Hokkaido, Japan
MDTomomasa Yoshimura
13Tomakomai Urology and Cardiology Clinic, Hokkaido, Japan
MDJunya Yamamoto
14Department of Nephrology, JCHO Hokkaido Hospital, Hokkaido, Japan
MDTakashi Kudo
9Department of Internal Medicine, Kushiro Red Cross Hospital, Hokkaido, Japan
MDMakoto Kondo
3Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Hokkaido, Japan
MDHiroshi Kataoka
3Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Hokkaido, Japan
MDMasaya Mukai
3Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Hokkaido, Japan
MDYukito Kaga
4Department of Clinical Laboratory, Sapporo City General Hospital, Hokkaido, Japan
BSMiku Yoshinari
4Department of Clinical Laboratory, Sapporo City General Hospital, Hokkaido, Japan
8Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Hokkaido, Japan
MSYuka Nishibata
8Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Hokkaido, Japan
BSSakiko Masuda
8Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Hokkaido, Japan
PhDUtano Tomaru
6Department of Surgical Pathology, Hokkaido University Hospital, Hokkaido, Japan
MDAkihiro Ishizu
8Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Hokkaido, Japan
MDYuichiro Fukasawa
1Department of Pathology, Sapporo City General Hospital, Hokkaido, Japan
MDSeiji Hashimoto
15Department of Nephrology, Kinan Hospital, Tanabe, Wakayama, Japan
MDSaori Nishio
7Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan
MD
Article usage
Posted December 05, 2022.
Bucillamine use for rheumatoid arthritis and type 2 diabetes mellitus are associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy
Takahiro Tsuji, Sari Iwasaki, Keishi Makita, Shota Furukawa, Kanako Watanabe-Kusunoki, Sayo Takeda-Otera, Takahito Itoh, Mamiko Shimamoto, Hiroaki Yamaji, Tomomasa Yoshimura, Junya Yamamoto, Takashi Kudo, Makoto Kondo, Hiroshi Kataoka, Masaya Mukai, Yukito Kaga, Miku Yoshinari, Yuka Nishibata, Sakiko Masuda, Utano Tomaru, Akihiro Ishizu, Yuichiro Fukasawa, Seiji Hashimoto, Saori Nishio
medRxiv 2022.12.02.22282616; doi: https://doi.org/10.1101/2022.12.02.22282616
Bucillamine use for rheumatoid arthritis and type 2 diabetes mellitus are associated with neural epidermal growth factor-like 1 (NELL1)-associated membranous nephropathy
Takahiro Tsuji, Sari Iwasaki, Keishi Makita, Shota Furukawa, Kanako Watanabe-Kusunoki, Sayo Takeda-Otera, Takahito Itoh, Mamiko Shimamoto, Hiroaki Yamaji, Tomomasa Yoshimura, Junya Yamamoto, Takashi Kudo, Makoto Kondo, Hiroshi Kataoka, Masaya Mukai, Yukito Kaga, Miku Yoshinari, Yuka Nishibata, Sakiko Masuda, Utano Tomaru, Akihiro Ishizu, Yuichiro Fukasawa, Seiji Hashimoto, Saori Nishio
medRxiv 2022.12.02.22282616; doi: https://doi.org/10.1101/2022.12.02.22282616
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)